| Literature DB >> 33936477 |
Sylvia Pelayo1, Jacques Bouaud2,3, Claudia Blancafort3, Jean-Baptiste Lamy3, Booma Devi Sekar4, Nekane Larburu5,6, Naiara Muro3,5,6, Ander Urruticoechea Ribate7, Jon Belloso7, Guillermo Valderas8, Sara Guardiola8, Charlotte Ngo9,10, Luis Teixeira11,10, Gilles Guézennec3, Brigitte Séroussi3,12.
Abstract
The DESIREE project has developed a platform offering several complementary therapeutic decision support systems (DSSs) to improve care quality for breast cancer patients. A first assessment of the system was carried out in close-to-real tumor boards (TBs). Fourteen TB sessions were organized corresponding to a total of 125 exploitable decisions previously made without the system and re-played with the system after a washout period in three pilot sites. Results show an overestimation of declared compliance with guidelines when not using the system as compared to measured compliance with the recommendations issued from the guideline-based DSS of DESIREE. After using the system, measured compliance rate of decisions with guidelines was significantly improved from 74.4% to 89.6%. Most of the changes in decisions when using the guideline-based DSS were associated with non-compliant decisions that became compliant. Qualitative analysis and interviews showed that despite maturity issues, clinicians found DESIREE DSSs innovative and promising. ©2020 AMIA - All rights reserved.Entities:
Year: 2021 PMID： 33936477 PMCID： PMC8075492
Source DB: PubMed Journal: AMIA Annu Symp Proc ISSN： 1559-4076